Speed That Survives Inspection
AI for a GxP world — validated, traceable, and submission-ready by design.
Life Sciences Can't Trade Compliance for Speed.
Manual evidence synthesis lengthens Phase II/III timelines.
Regulatory and submission work is effort-heavy and error-prone.
Trial and real-world data are hard to combine and harder to trust.
GxP validation makes every new tool expensive to adopt.
You need speed that stands up to inspection.
Engineering Antidotes
R&D Acceleration
Key Benefits
Faster literature review, evidence synthesis and analysis, every claim cited to source.
Primary Use Cases
Literature review, target identification, protocol design support, data analysis.
Regulatory Automation
Key Benefits
Faster drafting and dossier assembly, with an audit trail behind every section.
Primary Use Cases
Submission drafting, dossier assembly, response handling, change control.
Evidence Generation
Key Benefits
Trial and real-world data turned into submission-ready, defensible evidence.
Primary Use Cases
Real-world evidence studies, endpoint analysis, safety signal detection, HEOR support.
Validated Data Readiness
Key Benefits
Usable, traceable data across trials and real-world sources in a GxP environment.
Primary Use Cases
Data integration, lineage and traceability, validation documentation, master dat